The optical imaging market is consolidated at the top, with the 10 leading players accounting for nearly 80% of the market in 2013. Most of these players are based in developed countries across North America and Europe; however, some, such as Canon, Inc. (based in Japan), are situated in the APAC region.

The global optical imaging market is dominated by Carl Zeiss Meditec AG (Germany), St. Jude Medical, Inc. (U.S.), and Volcano Corporation (U.S.). Together, these players held a collective market share of around 50%-55% in 2013. St. Jude Medical, Inc. and Volcano Corporation have a diversified product portfolio for optical imaging, which includes OCT systems and catheters for intravascular imaging. Carl Zeiss held the largest market share in 2013, owing to its wide range of OCT product offerings for the market and the company’s strong presence in more than 50 countries across the globe. In the past few years, the company has strengthened its market position by launching innovative products for the market from time to time, and by acquiring smaller players in the market in an effort to expand its technological capabilities and geographic presence.

Some of the other major players in this market include Topcon Medical systems, Inc. (U.S.), and Canon, Inc. (Japan), PerkinElmer, Inc. (U.S.), Bioptigen, Inc. (U.S.), Heidelberg Engineering, Inc. (U.S.), Headwall Photonics (U.S.), and Optovue, Inc. (U.S.). These players held a significant share of the market, mainly due to their core technological expertise in OCT imaging and optical imaging software markets.

Apart from new product launches; agreements, partnerships and collaborations is another key growth strategy adopted by majority of the leading players in this market to expand their product portfolio or to increase their geographic presence. Being a technology intensive market, a number of players also focus on product enhancements as a key growth strategy in the optical imaging market.